Eli Lilly Cleared By Jury In Cymbalta Withdrawal Suit

Law360, Washington (September 1, 2015, 4:16 PM EDT) -- A Virginia federal jury cleared drugmaker Eli Lilly & Co. on Tuesday of allegations it had negligently downplayed the risks of Cymbalta withdrawal in its labeling, shooting down the last claims of a trimmed-down suit from two women who claimed they suffered severe withdrawal symptoms.

Plaintiffs claimed Eli Lilly negligently failed to warn their prescribing doctors by understating the withdrawal risks of Cymbalta, which included depression, migraines, pain, fatigue and sensations of electric shocks. (Credit: AP) The jury came back after less than three hours of...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Ali v. Eli Lilly and Company


Case Number

1:14-cv-01615

Court

Virginia Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Anthony J Trenga

Date Filed

November 25, 2014


Case Title

Hagan-Brown v. Eli Lilly and Company


Case Number

1:14-cv-01614

Court

Virginia Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Anthony J Trenga

Date Filed

November 25, 2014

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.